The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancer | Signal Transduction and Targeted Therapy
CRISPR in cancer biology and therapy | Nature Reviews Cancer
Controlling and enhancing CRISPR systems | Nature Chemical Biology
Beyond editing: repurposing CRISPR–Cas9 for precision genome regulation and interrogation | Nature Reviews Molecular Cell Biology
CRISPR screens for functional interrogation of immunity | Nature Reviews Immunology
Programmed genome editing by a miniature CRISPR-Cas12f nuclease | Nature Chemical Biology
The use of new CRISPR tools in cardiovascular research and medicine | Nature Reviews Cardiology
Efficient engineering of human and mouse primary cells using peptide-assisted genome editing | Nature Biotechnology
CRISPR–Cas: a tool for cancer research and therapeutics | Nature Reviews Clinical Oncology
The kill-switch for CRISPR that could make gene-editing safer
CRISPR-based diagnostics | Nature Biomedical Engineering
The chemistry of Cas9 and its CRISPR colleagues | Nature Reviews Chemistry
CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response | Nature Medicine
The next generation of CRISPR–Cas technologies and applications | Nature Reviews Molecular Cell Biology
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells | Nature
Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes | Nature Communications
CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology | npj Precision Oncology
Nature-inspired CRISPR enzymes for expansive genome editing | MIT News | Massachusetts Institute of Technology
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer | Nature Immunology
Cornerstones of CRISPR–Cas in drug discovery and therapy | Nature Reviews Drug Discovery
Nature Medicine - About the cover: Using CRISPR-Cas9–based genome editing technology, Sato and colleagues (featured on p 256 of this month's issue) introduce various combinations of mutations associated with human intestinal tumors
What's new in clinical CRISPR? | Nature Medicine
Enhanced proofreading governs CRISPR–Cas9 targeting accuracy | Nature
A first step toward in vivo gene editing in patients | Nature Medicine
Advances in CRISPR therapeutics | Nature Reviews Nephrology
New CRISPR-based tool inserts large DNA sequences at desired sites in cells | MIT News | Massachusetts Institute of Technology
